Global Reverse Transcription Kits Market Report 2026 | Capitalize on 8.4% CAGR as Roche, Thermo Fisher, Merck, QIAGEN and Promega Accelerate Automation and NGS

What happened: ResearchAndMarkets.com added the "Reverse Transcription Kits Global Market Report 2026," covering a market projected to grow from $1.68 billion in 2025 to $1.82 billion in 2026. Key numbers: 2025 market $1.68 billion; 2026 $1.82 billion; 2026 CAGR 8.2%; forecast $2.51 billion by 2030 at 8.4% CAGR; WHO projected 40 million to 60 million Why it matters: The report cites high-throughput kits, pharmaceutical R&D, and automated laboratory integration as forecast-period drivers, with Asia-Pacific expected to be the fastest-growing region and North America the largest in 2025. Market: +5.0% today ($148.04), +40.1% YTD, 0.5x vol — as of 16:47 UTC Verified: Q3_2026 (Oct 29) EPS $2.49 vs $2.09 est, +19.3% beat; next print ~Jan 28

ResearchAndMarkets.com added the "Reverse Transcription Kits Global Market Report 2026," covering a market projected to grow from $1.68 billion in 2025 to $1.82 billion in 2026.

The report cites high-throughput kits, pharmaceutical R&D, and automated laboratory integration as forecast-period drivers, with Asia-Pacific expected to be the fastest-growing region and North America the largest in 2025. Market: +5.0% today ($148.04), +40.1% YTD, 0.5x vol — as of 16:47 UTC Verified: Q3_2026 (Oct 29) EPS $2.49 vs $2.09 est, +19.3% beat; next print ~Jan 28